Biolexis Therapeutics is a cutting-edge FIELDS technology to design potent and selective small molecule therapeutics. The company was founded in 2021 by Dr. Hari Vankayalapati and Dr. David J. Bearss and is headquartered in Sandy, Utah, United States.
